3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Thapsigargin
Mechanistic comparison of 3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one [Supplementary Concept] and Thapsigargin based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
4
Shared Targets
24%
Jaccard Similarity
21%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one and Thapsigargin share 4 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.235 means 24% of the combined target set is bound by both compounds. The IDF-weighted score of 0.214 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
Related Comparisons
Similar to 3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one
3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Deslanoside4 targets3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Proscillaridin3 targets3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Phenylbutazone4 targets3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Homoharringtonine2 targets3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one vs Feprazone3 targets